FindTrial
Sign In

iopromide

DRUG6 trials

Sponsors

Ospedale San Donato, Guerbet, Yong Huo, Seoul National University Hospital, GE Healthcare

Conditions

Acute Myocardial InfarctionAdenocarcinoma, PancreasContrast Induced NephropathyCoronary Artery DiseaseHypothyroidismKidney Failure, ChronicNeuroendocrine Carcinoma of PancreasPost-ERCP Acute Pancreatitis

Phase 4

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
CompletedNCT00827788
Ospedale San DonatoAcute Myocardial Infarction, Contrast Induced Nephropathy
Start: 2008-12-31Target: 432Updated: 2010-11-16
Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
CompletedNCT01255722
GuerbetCoronary Artery Disease
Start: 2010-11-30End: 2012-09-30Updated: 2015-12-16
Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
NCT01580046
Yong HuoKidney Failure, Chronic
Start: 2012-04-30End: 2013-12-31Target: 200Updated: 2013-10-16
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
WithdrawnNCT03631771
GE HealthcareHypothyroidism
Start: 2022-03-31End: 2025-02-28Updated: 2022-04-20

Unknown Phase

Role of Perfusion CT in Pancreatic Cancer
NCT01703650
Seoul National University HospitalAdenocarcinoma, Pancreas, Neuroendocrine Carcinoma of Pancreas
Start: 2012-11-30End: 2021-09-30Updated: 2020-10-08
Low-acid Contrast Media for Preventing Post ERCP Pancreatitis
CompletedNCT07391787
Shandong UniversityPost-ERCP Acute Pancreatitis
Start: 2025-08-01End: 2026-01-15Updated: 2026-02-06